Conesa A, Madrigal P, Tarazona S, et al
In the GLP-1 space, we have made significant progress with eight contracts already signed and an additional 6-7 expected to be signed soon
Peptide of the Week: Kisspeptin & TA-1 Fertility, Hormones & Elite Immune Defense We are not doctors
External resources NEJM Phase 2 Trial: Triple Hormone Receptor Agonist Retatrutide for Obesity PMC Review: Retatrutide - A Game Changer in Obesity Pharmacotherapy ClinicalTrials.gov: Retatrutide TRIUMPH Clinical Trial Registry Nature Medicine: Retatrutide for Metabolic Dysfunction-Associated Steatotic Liver Disease For researchers serious about optimizing their retatrutide protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, personalized protocol builders, dosing calculators, and a community of thousands who have navigated these exact questions
Researchers call it a triple-hormone-receptor agonist
Opioid use disorder odds were 69 per cent lower